Literature DB >> 18992733

Free serum DNA is an early predictor of severity in acute pancreatitis.

Ivan Gornik1, Jasenka Wagner, Vladimir Gasparović, Gordan Lauc, Olga Gornik.   

Abstract

OBJECTIVES: Cell-free DNA has been investigated as a diagnostic marker in many diseases, including acute conditions. Our hypothesis was that in acute pancreatitis free serum DNA correlates with the extent of pancreatic necrosis and that it may be an early marker of severity. DESIGN AND METHODS: Free DNA was measured in sera from 30 patients with acute pancreatitis at admission, on the first, fourth and seventh day following admission.
RESULTS: On the first day following admission patients who would develop severe pancreatitis had significantly higher serum DNA levels than those with mild disease (median 0.271 ng/microL vs. 0.059 ng/microL respectively; P<0.001). This parameter showed very good characteristics as a potential severity predictor (area under ROC curve 0.97). Free serum DNA was in correlation with the extent of pancreatic necrosis.
CONCLUSIONS: Free serum DNA correlates with the extent of pancreatic necrosis and is a potential early marker of severe acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992733     DOI: 10.1016/j.clinbiochem.2008.09.121

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  15 in total

1.  Cell-free plasma DNA and purine nucleotide degradation markers following weightlifting exercise.

Authors:  Johanna Atamaniuk; Claudia Vidotto; Markus Kinzlbauer; Norbert Bachl; Beate Tiran; Harald Tschan
Journal:  Eur J Appl Physiol       Date:  2010-06-26       Impact factor: 3.078

2.  Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids.

Authors:  Vaneet K Sharma; Paul Vouros; James Glick
Journal:  Int J Mass Spectrom       Date:  2011-07       Impact factor: 1.986

3.  Postoperative immunosuppression markers and the occurrence of sepsis in patients with benign and malignant disease.

Authors:  Tamara Alkhamis; Dubravka Ivić; Jasenka Wagner; Josip Ivić; Blaženka Dobrošević; Ivana Turina; Kristina Kralik; Jerko Barbić
Journal:  Wien Klin Wochenschr       Date:  2014-10-03       Impact factor: 1.704

4.  Quantification of circulating cell-free DNA in the serum of patients with obstructive sleep apnea-hypopnea syndrome.

Authors:  Liang Ye; Guan-Hua Ma; Ling Chen; Min Li; Jia-Lin Liu; Kun Yang; Qing-Yun Li; Ning Li; Huan-Ying Wan
Journal:  Lung       Date:  2010-07-29       Impact factor: 2.584

Review 5.  Cell death and DAMPs in acute pancreatitis.

Authors:  Rui Kang; Michael T Lotze; Herbert J Zeh; Timothy R Billiar; Daolin Tang
Journal:  Mol Med       Date:  2014-10-29       Impact factor: 6.354

6.  Plasma cell-free DNA in patients needing mechanical ventilation.

Authors:  Marjatta Okkonen; Päivi Lakkisto; Anna-Maija Korhonen; Ilkka Parviai-nen; Matti Reinikainen; Tero Varpula; Ville Pettilä
Journal:  Crit Care       Date:  2011-08-12       Impact factor: 9.097

7.  Decreased serum cell-free DNA levels in rheumatoid arthritis.

Authors:  Marina Dunaeva; Bastiaan C Buddingh'; René E M Toes; Jolanda J Luime; Erik Lubberts; Ger J M Pruijn
Journal:  Auto Immun Highlights       Date:  2015-06-27

Review 8.  Free DNA--new potential analyte in clinical laboratory diagnostics?

Authors:  Jasenka Wagner
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

Review 9.  Prognostic value of circulating DNA levels in critically ill and trauma patients.

Authors:  Edison Moraes Rodrigues Filho; Nilo Ikuta; Daniel Simon; Andrea Pereira Regner
Journal:  Rev Bras Ter Intensiva       Date:  2014 Jul-Sep

Review 10.  The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.

Authors:  Yahya I Elshimali; Husseina Khaddour; Marianna Sarkissyan; Yanyuan Wu; Jaydutt V Vadgama
Journal:  Int J Mol Sci       Date:  2013-09-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.